OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...

OpenAI CEO Sam Altman is set to hold a private briefing ... Sources suggest OpenAI is nearing the release of “super-agents”—AI systems capable of performing complex, Ph.D.-level tasks ...

Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence, superintelligence, agentic AI, and more — and when ...

OpenAI, led by CEO Sam Altman, is backing an initiative known as AI 2030, which is aimed at shaping "public dialogue about U.S. competition against China on AI," Politico reported in October.

ForbesMusk Bashes Trump’s New Stargate AI Initiative With OpenAI And Oracle As ‘Fake’—Here’s WhyBy Derek Saul ForbesOpenAI’s Sam Altman Says He ‘Changed His Perspective’ On Trump ...

OpenAI CEO Sam Altman suggested Elon Musk cares more about his businesses than he does the country, shortly after he referred to Musk as "the most inspiring entrepreneur of our time." ...